Tyrosine hydroxylase-immunoreactive neurons are decreased in number in the cerebral cortex of Parkinson's disease

Neuropathology

Volumn 19, Issue 1, 1999, Pages 10-13

  Fukuda, T ^a   Takahashi, J ^a   Tanaka, J ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral cortex; Neuron; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

ANTIBODY; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CELL; BRAIN CORTEX; CELL COUNT; CELL DENSITY; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULA; LEWY BODY; LIMBIC SYSTEM; LOCUS CERULEUS; MALE; NEOCORTEX; NERVE CELL; OLIVARY NUCLEUS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBICULUM;

EID: 0033033276     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.1999.00196.x     Document Type: Article

References (20)

1. 1 Hökfelt T, Johansson O, Goldstein M. Central catecholamine neurons as revealed by immunohisto‐chemistry with special reference to adrenaline neurons. In: Björklund A, Hökfelt T (eds). Handbook of Chemical Neuroanatomy, 1st edn. Amsterdam: Elsevier, 1984; 170–186.
2. 2 Berger B, Verney C, Alvarez C, Vigny A, Helle KB. New dopaminergic terminal fields in the motor, visual (area 18b) and retrosplenial cortex in the young and adult rat. Immunocytochemical and catecholamine histoche‐mical analyses. Neuroscience 1985 ; 15: 983–998.
3. 3 Specht LA, Pickel VM, Joh TH, Reis DJ. Light‐microscopic immunocytochemical localization of tyrosine‐hydroxylase in prenatal rat brain. II. Late ontogeny. J Comp Neurol 1981 ; 199: 255–276. DOI: 10.1002/cne.901990208
4. 4 Kosaka T, Hama K, Nagatsu I. Tyrosine hydroxylase‐immunoreactive intrinsic neurons in the rat cerebral cortex. Exp Brain Res 1987 ; 68: 393–405.
5. 5 Gaspar P, Berger B, Febvret A, Vigny A, Krieger‐Poulet M, Borri‐Voltattorni C. Tyrosine hydroxylase‐immunoreactive neurons in the human cerebral cortex: A novel catecholaminergic group? Neurosci Lett 1987 ; 80: 257–262. DOI: 10.1016/0304-3940(87)90464-2
6. 6 Hornung JP, Törk I, De Tribolet N. Morphology of tyrosine hydroxylase‐immunoreactive neurons in the human cerebral cortex. Exp Brain Res 1989 ; 76: 12–20.
7. 7 Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree–A new disease? Clin Neuropathol 1984 ; 3: 185–192.
8. 8 Halliday GM, Li YW, Blumbergs PC et al. Neuro‐pathology of immunohistochemically identified brain‐stem neurons in Parkinson's disease. Ann Neurol 1990 ; 27: 373–385. DOI: 10.1002/ana.410270405
9. 9 Chan‐Palay V & Asan E. Alterations in catecholamine neurons of the locus ceruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 1989 ; 287: 373–392.
10. 10 Kosaka T, Kosaka K, Hataguchi Y et al. Catechol‐aminergic neurons containing GABA‐like and/or glutamic acid decarboxylase‐like immunoreactivities in various brain regions of the rat. Exp Brain Res 1987 ; 66: 191–210.
11. 11 Trottier S, Geffard M, Evrard B. Co‐localization of tyrosine hydroxylase and GABA immunoreactivities in human cortical neurons. Neurosci Lett 1989 ; 106: 76–82. DOI: 10.1016/0304-3940(89)90205-X
12. 12 Mugnaini E & Oertel WH. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T (eds). Handbook of Chemical Neuroanatomy, Vol 4. GABA and Neuropeptides in the CNS, Part I. Amsterdam: Elsevier 1985; 436–608.
13. 13 Girotti F, Soliveri P, Carella F et al. Dementia and cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988 ; 51: 1498–1502.
14. 14 Perry EK, Curtis M, Dick DJ et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985 ; 48: 413–421.
15. 15 Chan‐Palay V & Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 1989 ; 287: 373–392.
16. 16 Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990 ; 237: 197–204. DOI: 10.1007/BF00314594
17. 17 Iwatsubo T, Nakano I, Fukunaga K, Miyamoto E. Ca 2+ /calmodulin‐dependent protein kinase II immuno‐reactivity in Lewy bodies. Acta Neuropathol (Berl) 1991 ; 82: 159–163. DOI: 10.1007/BF00294440
18. 18 Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body‐containing neurons are pyramidal cells: Laser confocal imaging of double‐immunolabeled sections with anti‐ubiquitin and SMI32. Acta Neuropathol (Berl) 1995 ; 89: 404–408.
19. 19 Kuljis RO, Martin‐Vasallo P, Peress NS. Lewy bodies in tyrosine hydroxylase‐synthesizing neurons of the human cerebral cortex. Neurosci Lett 1989 ; 106: 49– 54. DOI: 10.1016/0304-3940(89)90200-0
20. 20 Dickson DW, Davies P, Mayeux R et al. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (Berl) 1987 ; 75: 8–15. DOI: 10.1007/BF00686786